Jie Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jie Li has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Jianming Wang
Department of Traditional Chinese Medicine Rheumatology, China-Japan Friendship Hospital, Beijing 100029, China
1 shared publication - Jiayu Zhang
School of Pharmacy, Binzhou Medical University, Yantai, China
1 shared publication - Jun Jia
Research Institute, Beijing Tong Ren Tang Technology Development Co., Ltd., Pharmaceutical Factory, Beijing 100051, China
1 shared publication Meiqi Lan
1 shared publication- Wenjun Sun
Department of Encephalopathy, Beijing University of Chinese Medicine Third Affiliated Hospital
1 shared publication - Xue Zhao
College of Pharmaceutical Science, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China
1 shared publication
Latest Publications
- 5 May 2026
- Published by Bentham Science Publishers Ltd. in Current Drug Metabolism
- Vol. 27, 1-31
Unraveling the Gut Microbiota-Mediated Mechanism of Guogong Jiu for Rheumatoid Arthritis Treatment through Network Pharmacology and Metabolomics
Introduction: Rheumatoid Arthritis (RA) is a chronic autoimmune inflammatory disease. Guogong Jiu (GGJ) is a classical traditional Chinese medicine formula that is widely used in clinical treatment of rheumatoid arthritis. Nevertheless, the gut microbiota and meta-bolic mechanisms have not been fully studied. The objective of this study was to elucidate the gut microbiota-mediated mechanisms by which GGJ alleviates RA using network phar-macology, metabolomics, and experimental approaches. Methods: A rat model of collagen-induced arthritis was established to assess anti-arthritic effects systemically. The arthritis index, histopathology, inflammatory cytokines, and gut mi-crobiota analysis (16S rRNA) were assessed for their effects. The serum and fecal metabo-lomics were done using UHPLC-Q-Exactive MS/MS. Moreover, network pharmacology and secondary metabolome analysis were used to identify the active herbal components, potential targets, and pathways, which were validated in Rheumatoid Arthritis Fibroblast-Like Syno-viocytes (RA-FLS) as well. Results: GGJ improved the symptoms of Rheumatoid arthritis. GGJ affected pathways in-volved in amino acid, lipid, and energy metabolism. Moreover, the assessment of gut micro-biota revealed that GGJ helped restore microbial equilibrium by augmenting beneficial bac-teria populations, including Lactobacillus and Alloprevotella, alongside diminishing Prevotella abundance. An integrated analysis identified NF-κB, MAPK, and NRF2 as key targets, which were subsequently validated at the cellular level. Discussion: The multi-omics integration reveals that GGJ exerts its therapeutic effects through coordinated regulation of the gut-joint axis, involving microbiota restoration, meta-bolic reprogramming, and signaling pathways. These findings provide a mechanistic basis for the clinical application of GGJ in RA. Conclusion: GGJ is effective in RA through multi-target effects involving modulation of inflammatory signaling pathways, mediation of metabolic reprogramming, and restoration of gut microbiota. The clinical application of GGJ for RA is therefore scientifically supported.
- 5 May 2026
- Published by Bentham Science Publishers Ltd. in Current Drug Metabolism
- Vol. 27, 1-31
Unraveling the Gut Microbiota-Mediated Mechanism of Guogong Jiu for Rheumatoid Arthritis Treatment through Network Pharmacology and Metabolomics
Introduction: Rheumatoid Arthritis (RA) is a chronic autoimmune inflammatory disease. Guogong Jiu (GGJ) is a classical traditional Chinese medicine formula that is widely used in clinical treatment of rheumatoid arthritis. Nevertheless, the gut microbiota and meta-bolic mechanisms have not been fully studied. The objective of this study was to elucidate the gut microbiota-mediated mechanisms by which GGJ alleviates RA using network phar-macology, metabolomics, and experimental approaches. Methods: A rat model of collagen-induced arthritis was established to assess anti-arthritic effects systemically. The arthritis index, histopathology, inflammatory cytokines, and gut mi-crobiota analysis (16S rRNA) were assessed for their effects. The serum and fecal metabo-lomics were done using UHPLC-Q-Exactive MS/MS. Moreover, network pharmacology and secondary metabolome analysis were used to identify the active herbal components, potential targets, and pathways, which were validated in Rheumatoid Arthritis Fibroblast-Like Syno-viocytes (RA-FLS) as well. Results: GGJ improved the symptoms of Rheumatoid arthritis. GGJ affected pathways in-volved in amino acid, lipid, and energy metabolism. Moreover, the assessment of gut micro-biota revealed that GGJ helped restore microbial equilibrium by augmenting beneficial bac-teria populations, including Lactobacillus and Alloprevotella, alongside diminishing Prevotella abundance. An integrated analysis identified NF-κB, MAPK, and NRF2 as key targets, which were subsequently validated at the cellular level. Discussion: The multi-omics integration reveals that GGJ exerts its therapeutic effects through coordinated regulation of the gut-joint axis, involving microbiota restoration, meta-bolic reprogramming, and signaling pathways. These findings provide a mechanistic basis for the clinical application of GGJ in RA. Conclusion: GGJ is effective in RA through multi-target effects involving modulation of inflammatory signaling pathways, mediation of metabolic reprogramming, and restoration of gut microbiota. The clinical application of GGJ for RA is therefore scientifically supported.
- Open Access
- 1 November 2025
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 18, 7593-7608
Integrating Bibliometrics and Bioinformatics to Map Knowledge Structure and Trend Synthesis in Rheumatoid Arthritis and Bone Erosion (2015–2024)
To comprehensively analyze the international trends and dynamics in rheumatoid arthritis and bone erosion research over the past 10 years, identifying research hotspots and challenges to provide references for future research directions and therapeutic strategies. A bibliometric analysis was conducted by retrieving relevant literature published between 2015 and 2024 from the Web of Science (WoS) database. A further bibliometric analysis and visualization of the relevant literature was conducted using CiteSpace, VOSviewer, Scimago Graphica, and Excel. Further, disease-related targets were retrieved from Genecards using “rheumatoid arthritis” and “bone erosion” as keywords, followed by PPI network analysis to identify core targets and KEGG pathway enrichment analysis to elucidate key signaling pathways. A total of 1,502 publications were included through a search of the WoS database. The number of publications initially showed a gradual increase but declined sharply after 2021. China and the United States ranked as the top two contributors, with China’s proportion of publications increasing while the US proportion decreased. Cluster analysis of institutional collaboration networks revealed significant regional clustering. Arthritis Research & Therapy published the most articles in this field, while Schett, Georg ranked first in both the number of publications (34) and citations (1,436). Keyword cluster analysis indicated that research primarily focused on imaging and mechanistic exploration. PPI and KEGG analyses revealed that rheumatoid arthritis (RA) and bone erosion are closely associated with inflammatory factors and inflammation-related signaling pathways. This study highlights the evolving trends in rheumatoid arthritis and bone erosion research from 2015 to 2024, demonstrating China’s growing research contributions while international collaboration remains regionally concentrated. Future efforts should emphasize interdisciplinary integration and global cooperation to advance the understanding of bone erosion mechanisms and precision medicine approaches.
- 1 November 2025
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 18, 7593-7608
Open AccessIntegrating Bibliometrics and Bioinformatics to Map Knowledge Structure and Trend Synthesis in Rheumatoid Arthritis and Bone Erosion (2015–2024)
To comprehensively analyze the international trends and dynamics in rheumatoid arthritis and bone erosion research over the past 10 years, identifying research hotspots and challenges to provide references for future research directions and therapeutic strategies. A bibliometric analysis was conducted by retrieving relevant literature published between 2015 and 2024 from the Web of Science (WoS) database. A further bibliometric analysis and visualization of the relevant literature was conducted using CiteSpace, VOSviewer, Scimago Graphica, and Excel. Further, disease-related targets were retrieved from Genecards using “rheumatoid arthritis” and “bone erosion” as keywords, followed by PPI network analysis to identify core targets and KEGG pathway enrichment analysis to elucidate key signaling pathways. A total of 1,502 publications were included through a search of the WoS database. The number of publications initially showed a gradual increase but declined sharply after 2021. China and the United States ranked as the top two contributors, with China’s proportion of publications increasing while the US proportion decreased. Cluster analysis of institutional collaboration networks revealed significant regional clustering. Arthritis Research & Therapy published the most articles in this field, while Schett, Georg ranked first in both the number of publications (34) and citations (1,436). Keyword cluster analysis indicated that research primarily focused on imaging and mechanistic exploration. PPI and KEGG analyses revealed that rheumatoid arthritis (RA) and bone erosion are closely associated with inflammatory factors and inflammation-related signaling pathways. This study highlights the evolving trends in rheumatoid arthritis and bone erosion research from 2015 to 2024, demonstrating China’s growing research contributions while international collaboration remains regionally concentrated. Future efforts should emphasize interdisciplinary integration and global cooperation to advance the understanding of bone erosion mechanisms and precision medicine approaches.